Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
Pulmonary Therapy|February 7, 2020
Predictors of Symptom Burden in Patients with COPD on LAMA Monotherapy: Multivariable Analysis of a Claims-Linked Survey StudyBeth Hahn, Richard H Stanford, Alyssa Goolsby Hunter, et al.Pulmonary Therapy|February 7, 2020
Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey StudyRiju Ray, Beth Hahn, Richard H Stanford, et al.Behavioural Brain Research|July 5, 2008
Neuroimaging, genetics and the treatment of nicotine addictionRiju Ray, James Loughead, Ze Wang, et al.Respiratory Medicine|June 3, 2018
Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABABeth Hahn, Michael Hull, Cori Blauer-Peterson, et al.International Journal of Chronic Obstructive Pulmonary Disease|November 5, 2020
Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol TherapyChad Moretz, Beth Hahn, John White, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 1, 2008
Identification of pharmacogenetic markers in smoking cessation therapyDaniel F Heitjan, Mengye Guo, Riju Ray, et al.Neuroscience Letters|May 24, 2008
Nicotine abstinence-induced cerebral blood flow changes by genotypeZe Wang, Riju Ray, Myles Faith, et al.Drugs & Aging|June 29, 2018
Efficacy of Umeclidinium/Vilanterol in Elderly Patients with COPD: A Pooled Analysis of Randomized Controlled TrialsRiju Ray, Lee Tombs, Michael J Asmus, et al.Postgraduate Medicine|January 5, 2020
Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β<sub>2</sub>-agonist bronchodilatorsNeil S Skolnik, Trang Susan Nguyen, Aarisha Shrestha, et al.Biological Psychiatry|March 9, 2010
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokersJames Loughead, Riju Ray, E Paul Wileyto, et al.Pageof 5